E89R
TEAS SECTION 8 & 9 RECEIVED
17/06/2026
Voltar para busca
Dado oficial do USPTO
BIOLOGICS CONSULTING
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
18/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 42, 45
Data de depósito
10/09/2015
Data de registro
28/03/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/09/2023
Última transação
18/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
15/01/2016
Primeiro uso no comércio
15/01/2016
Código do desenho
3
Tipo de titular
03
Localização do titular
Alexandria, VA, US
Examinador
BROWN, TRICIA
Unidade examinadora
N30
Localização atual
TMO LAW OFFICE 121
Descrição da marca
The mark consists of the word "BIOLOGICS" above "CONSULTING" with the design of connecting circles to the left of such words.
Titulares e representantes
Titulares
Biologics Consulting Group, Inc.
Representantes
Nicole J. Harrell Kaufman & Canoles, P.C.
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; regulatory submission managementassisting others in preparing and filing applications for new medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology with governmental regulatory bodies around the world; regulatory submission managementproviding simultaneous multiple country submissions of applications for the registration and approval of medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology; providing information online regarding regulatory submission management; business management consultingstrategic planning and business advisory services provided to medicalmedical technologybiopharmaceuticalbiotechnology companiesgovernment agencieseducational and research institutionslaw firmsinvestment firms in the fields of biologicspharmaceuticals and medical devices; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug and medical device approval; regulatory submission managementassisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; business consulting services in the field of biologicspharmaceuticalsprescription drugs and medical devices
Classe 42
Consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; product research and development for others in the fields of biologicspharmaceuticalsprescription drugs and medical devices; quality management servicesquality evaluation and analysisquality assurance and quality control in the field of biologicspharmaceuticalsprescription drugs and medical devices; scientific consulting and research services relating to the field of pharmaceuticalsmedical deviceslife sciencesbiologymedicine; consulting services in the fields of biotechnology and pharmaceuticalsdesigndevelopmenttechnical verification and technical validation of manufacturing and filling processesdrug formulationstesting protocols and analytical methods; and scientific and technological servicesscientific researchanalysistestingrelated scientific studies in the field of chemistry and molecular biologybiologics and protein detectioncharacterizationanalysis and testing; consulting services in the field of medical device product approval for commercial purposes
Classe 45
Regulatory compliance consulting servicesreviewing standards and practices to assist clients with compliance with governmental lawsregulations and rules in the fields of medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology; providing technical regulatory affair consulting services directed to medicalmedical technologybiopharmaceuticalbiotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical devicesmedical technologiesmedicationsbiopharmaceuticalsbiotechnology; and regulatory compliance consulting in the fields of biologicspharmaceuticalsprescription drugs and medical devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
28/03/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/05/2025
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
21/04/2025
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
21/04/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
18/09/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
18/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18/09/2023
E815
TEAS SECTION 8 & 15 RECEIVED
16/03/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
28/03/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
22/02/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/02/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/02/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/02/2017
IUAF
USE AMENDMENT FILED
16/01/2017
EISU
TEAS STATEMENT OF USE RECEIVED
16/01/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/08/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/06/2016
PUBO
PUBLISHED FOR OPPOSITION
21/06/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/05/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
18/05/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/05/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
18/05/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/05/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/01/2016
GNRT
NON-FINAL ACTION E-MAILED
04/01/2016
CNRT
NON-FINAL ACTION WRITTEN
04/01/2016
DOCK
ASSIGNED TO EXAMINER
22/12/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
16/09/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2015
NWAP
NEW APPLICATION ENTERED
14/09/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOLOGICS CONSULTING ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.